Biotech events - Theoria Creative

BioPharm America
2024-09-11 - 2024-09-12
LSX World Congress USA will replicate the unique dynamics and high-quality senior audience that has become the hallmark of LSX events around the world. In September 2024, we’ll be gathering North America’s leading Biotech, Medtech and Healthtech CEOs for a 2-day executive conference, in-person 1-2-1 partnering and company showcasing opportunities.
The CEOs from our network will be joined by the sectors most active investors, big pharma and commercial leaders as well as a selection of the highest-quality, trusted advisors. So, pack your bags, get out from behind your desks and join us in glorious Boston for some inspiring content, quality peer-to-peer discussion and high-level networking!

Baird's Global Healthcare Conference
2024-09-10 - 2024-09-11
Baird is delighted to host its annual Global Healthcare Conference. This conference brings institutional and private equity investors together with senior management from over 90 public and privately-held companies. The conference will feature companies across the following sectors: Biotechnology, Healthcare Supply Chain & Pharma Services, Healthcare Information Technology, Life Sciences & Diagnostics, Medical Technology and Facilities & Services. Baird conferences are by invitation only; reach out to your Baird Representative for additional details.

Fierce Digital Pharma East
2024-09-09 - 2024-09-12
Digital Pharma East is dedicated to advancing pharma marketing innovation beyond limits. Get ready for an immersive, informative, and thought-provoking event featuring top-tier keynote speakers, insightful case studies, engaging panel discussions, and much more.

H.C. Wainwright Annual Global Investment Conference
2024-09-09 - 2024-09-11
Join us for leading industry keynote speakers & presenting companies, investor one-on-one meetings, networking opportunities with attendees, and an evening of entertainment.

Charles River Biotech Symposium
2024-09-08 - 2024-09-11
The Charles River Biotech Symposium unites drug development professionals in an interactive setting to discuss the nonclinical development of biotherapeutics, including regulatory issues and innovative approaches to problem solving. The collegial spirit of this meeting creates exceptional opportunities for information sharing and networking. Please join us in beautiful Southern California for another unique and exciting educational opportunity.

Morgan Stanley Healthcare Conference
2024-09-04 - 2024-09-06
Morgan Stanley 22nd Annual Global Healthcare Conference, NYC

Wells Fargo Healthcare Conference
2024-09-04 - 2024-09-06

Informa RNA Leaders USA Congress
2024-09-04 - 2024-09-05
RNA Leaders USA Congress helps you to discover, develop & get to market by assessing new data & case studies from global RNA experts across Oligo-Based Therapeutics, mRNA Vaccines & Therapeutics and Next Gen RNA & Delivery Tools.

16th Annual BioProcessing Summit
2024-08-19 - 2024-08-22
Welcome to the Bioprocessing Summit!
Join us as we bring together thought leaders and pioneers in bioprocess R&D, scale-up, quality, and analytics. Explore cutting-edge research, exchange insights with industry experts, and chart the course for advancements that will shape the future of bioprocessing.
The Summit features main conference sessions, in-depth training seminars, a 1-day investor conference for C-level executives, a workshop dedicated to talent recruitment, acquisition and retention strategies, an engaging exhibit hall and a plethora of networking opportunities. Elevate your knowledge, expand your network, and be at the forefront of bioprocess innovation.

Breaking into the Business of Biotech
2024-07-17
Join Biotech Connection for an evening where we delve into the different layers of business development that make up successful biotech companies, and how to enter those spaces as a STEM PhD. Listen to a panel of professionals specializing in business development that will educate attendees on its importance in pharma and throughout all the life stages a biotech company experiences.

Demy Colton's Biotech CEO Summit
2024-07-15 - 2024-07-17
THE BIOTECH CEO SUMMITS – UNLIKE ANY OTHER CONFERENCE
The Biotech CEO Summits are unlike most meetings CEOs attend. It is not an investor conference nor is it a business development conference. Rather, the Summits’ focus is on the CEOs and the challenges they have leading their companies. The program is modeled after a think tank-style meeting with discussions led by subject matter experts with input from the CEOs. The CEOs benefit from the wisdom and experiences shared by other participating CEOs and the discussants.
The Summits operate under Chatham House Rules to encourage open and frank conversations. The number of participants is limited to allow full engagement. Registration is not open; one has to be asked to join this event. The Summits are closed to media and the sessions are not recorded in order to provide an extra layer of privacy.
If you are the CEO of a biotech company and are interested in attending this gathering, please send an email to ltaylor@demy-colton.com with your contact details and a link to your company website. The organizers will respond quickly.

PHC's Health Equity Leadership Summit
2024-07-11 - 2024-07-12
This event provides an opportunity for physicians, executives, advocates, and allies to find community, engage in hands-on trainings and workshops, and hold in-depth conversations about how they are addressing the issue of health equity in California through their care of underserved communities throughout the state.
Attendees will leave feeling energized and inspired to continue their important work to improve the lives of all Californians.

STING & TLR Targeted Therapies Summit
2024-06-19 - 2024-06-20
The STING & TLR Targeted Therapies Summit returns as the only industry-led event converging those with crucial insights to fuel the long-awaited success of innate immunity targeted therapies.
With the field venturing into new approaches to strike that balance between safety and efficacy, from immune agonist conjugates to combination approaches and novel dosing methods, stay ahead of this evolving field with the latest insights to steer you towards success in the clinic.
The therapeutic potential of harnessing the innate immune system has been waiting to be untapped for a while. Hear from the leading minds in immune-oncology and join the dedicated community to breakthrough barriers to success within your innate immunotherapy pipeline.

Goldman Sachs 45th Annual Global Healthcare Conference
2024-06-10 - 2024-06-13
Goldman Sachs cordially invites you to register for our 45th Annual Global Healthcare Conference to be held on Monday, June 10 through Thursday, June 13, 2024 at the Loews Miami Beach Hotel in Miami.
The conference will feature Q&A sessions moderated by Goldman Sachs analysts with companies across the spectrum of the global healthcare industry, including pharmaceuticals, biotechnology, life science tools, managed care, providers, medical devices and healthcare technology. We will also feature tracks with early-stage private companies working on transformative ideas across the healthcare sector — descriptions are included in the private company agenda. Investors will have the opportunity for one-on-one and group management meetings.
Please complete the online registration form by Friday, April 19 to register for the conference. Once you register online, we encourage you to return to the site regularly for up-to-date information.
We look forward to seeing you.

NNS 41st annual Neurotrauma Symposium
2024-06-09 - 2024-06-12
It is our distinct pleasure to invite you to attend the 41st annual National Neurotrauma Society Symposium, to be held in San Francisco, CA on June 9 – 12th, 2024, at the San Francisco Hilton Union Square. As in previous years, the NNS will co-host this meeting with the American Association of Neurological Surgeons/CNS Joint Section on Neurotrauma & Critical Care.
We look forward to seeing everyone in San Francisco!
Since its inception, the NNS symposia have brought together scientists, clinicians, and health-care providers who are dedicated to the study of neurotrauma and to translating knowledge generated by research into improved patient care.
Join your colleagues and initiate new collaborations at the premier forum for information related to traumatic brain injury and spinal cord injury.
The annual Neurotrauma Symposia are co-hosted by the National Neurotrauma Society and the American Association Neurological Surgeons and Joint Section on Neurotrauma and Critical Care (AANS/CNS). This combination of expertise allows for presentations that integrate state-of-the-art clinical, translational, and basic science data. Share with others what function means to you and hear about cutting edge approaches to assessing and improving function after neurotrauma.
The Scientific Program Committees are charged with putting together programs comprised of plenary and break-out sessions in which the leading experts will share their up-to-date research and findings in neurotrauma.
A central focus of the Symposium are the highly interactive poster sessions which stimulate scholarly discussions on the mechanisms, assessments and treatments for improving function after neurotrauma.

Jefferies Global Healthcare Conference
2024-06-05 - 2024-06-06
As an active and engaged participant in the financial community and the industries we serve, Jefferies hosts various investor conferences and summits throughout the year.
The Jefferies 2023 & 2024 Investor Conference & Summit Calendars are available below. Please check back periodically for updates & contact your Jefferies representative for more information.

Bio International Convention
2024-06-03 - 2024-06-06
BUILDING CONNECTIONS,
BREAKING BARRIERS
When the stakes are this high, we can’t go it alone. BIO unites a global network of business leaders, policymakers, investors and scientists for a common purpose: curing patients, protecting the planet, and nourishing humanity.

Annual Oncology Innovation Summit: Insights for ASCO & EHA
2024-05-31 - 2024-06-04
Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.
The 2024 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme: The Art and Science of Cancer Care: From Comfort to Cure.

Annual Meeting of the International Society for Cell & Gene Therapy (ISCT)
2024-05-29 - 2024-06-01
CUTTING EDGE TRANSLATIONAL CONTENT
Connect with global experts from across academic, regulatory, and industry. Participate in robust debates, collaborate on developing solutions to sector challenges, and secure a front-row seat to presentations and conversations advancing the field of cell and gene therapy.
50+ Roundtable Sessions: Developed by harnessing the expertise of key opinion leaders from ISCT expert committees, ISCT 2024 roundtable sessions provide an interactive platform for in-depth discussions and debates on pivotal subjects including iPSCs, exosomes, CAR-Ts, artificial intelligence, bio-manufacturing and regulatory harmonization.
Join our roundtable sessions to remain well-informed on solutions to the sector’s most pressing challenges, engage in conversations propelling the industry forward, and forge connections with potential future collaborators.
Translational Pathway Program: Immerse yourself in the future of cell and gene therapy with thought-provoking talks and presentations from the most esteemed cell and gene therapy leaders from across the globe. Our Translational Pathway Program provides key education and data on the most novel research spanning the spectrum of translation including science and innovation, translation to the clinic, first in human to clinical acceleration, launch and patient access.
Attend our plenary and concurrent sessions to discover the latest breakthroughs in gene-edited EVs, autologous and allogeneic iPSC clinical trials, CAR-Ts, NK cells, Tregs, point-of-care manufacturing, clinical site qualification standardization, investment and partnering.
Global Showcases & Corporate Sessions: Hear directly from industry leaders representing prominent international organizations to discover the current status of commercialization efforts in the cell and gene sector. Gain firsthand knowledge and education about the revolutionary technologies on the horizon that are poised to define the future of cell and gene therapy.

Pharma Partnering Summit
2024-05-14 - 2024-05-15
The Pharma Partnering US Summit 2024 is an exclusive and one of the most prestigious life sciences deal-making international conferences coming to San Diego, CA, on the 14th & 15th of May 2024.
This platform brings together senior executives and professionals from different parts of the world, focusing on business development and licensing, R&D collaborations, commercialization and distribution deals, fundraising, investments, alliances, M&A, Going Public, and partnering opportunities in the broader aspects.
Finally, San Diego has a supportive regulatory environment that encourages innovation and growth in the biotech industry. The state of California has implemented several initiatives to promote the life sciences sector, including tax incentives, grants, and loans for biotech companies.

2024 AAPS National Biotechnology Conference
2024-05-13 - 2024-05-16
Track 1: Advances in Discovery, Formulation, and Delivery of New Modalities
A tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and new modalities. Submissions are invited on topics related to multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, cells, and allogenic and synthetic cells. Discussions are encouraged on diverse strategies for the discovery, formulation, and delivery of these modalities to address unmet medical needs.
Track 2: Novel Strategies to Advance Biotherapeutic Development
Advances in therapeutic development for targeted delivery, platform technology, high-content bioanalysis, and data science.

ASGCT 27th Annual Meeting
2024-05-07 - 2024-05-11
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. ASGCT’s annual meeting brings together more than 3,400 professionals including scientists, physicians, and patient advocates.

APA 2024 Annual Meeting
2024-05-04 - 2024-05-08
Join APA for five days of sessions, courses, and more in the vibrant New York City to leave you feeling inspired, energized, and better prepared. Connect with colleagues and industry experts from around the globe. Choose from 500+ educational sessions led by psychiatry and mental health expert educators. Engage with an array of exhibitors featuring the latest therapeutics and technologies in psychiatry.
Can’t make it to NYC? We’ve got you covered. The Virtual Annual Meeting will feature live-streams of a limited selection of sessions from New York, all accessible from the comfort of your home or office, or anywhere with a secure internet connection.
Register before February 6 for our best Early Registration rates for the in-person-only experience. Registration for the virtual-only experience opens in February 2024.

Immunology 2024
2024-05-03 - 2024-05-07
Join us Friday, May 3, to Tuesday, May 7, in Chicago for the leading annual all-immunology event worldwide!
Explore the latest developments in your field.
Attend lectures by the world’s most prominent scientists.
Speak with poster authors presenting their cutting-edge data.
Network with colleagues from around the world.
There has never been a more important time for the immunology community to gather and share the latest cutting-edge science!

ASMB - Pathobiology 2024: Mechanisms of Disease
2024-04-20 - 2024-04-23
Tissue, Matrix, and Pathobiology is an exciting new multidisciplinary and collaborative joint meeting of the American Society for Matrix Biology (ASMB), The Histochemical Society (HCS), and the American Society for Investigative Pathology (ASIP). The Program Committee has put together a fantastic four-day lineup of speakers, career sessions, workshops, and events—and can’t wait to welcome you in Salt Lake City!
The annual meeting includes symposia and workshops communicating cutting edge scientific sessions, commingled with educational and professional development sessions appealing to trainees and junior faculty. Reflecting the ASIP membership, there will be a strong emphasis on:
Liver Pathobiology
Neuropathology
Gene Expression
Inflammation
Immunopathology
Vascular Biology
Neoplasia
Endothelial and Epithelial Cell Biology
Cancer Pathobiology
Fundamental Cell Biology

Bio-IT World - AI for Drug Discovery and Development
2024-04-16 - 2024-04-17
Leverage Artificial Intelligence and Machine Learning for Optimal Speed and Efficiency in Advancing Drug Discovery and Development Pipelines
The AI for Drug Discovery and Development track delves into the opportunities and obstacles faced by biopharma entities as they leverage the capabilities of artificial intelligence and machine learning technologies to optimize and expedite the entire drug discovery and development process, spanning from the initial stages to practical implementation. Speakers will examine AI’s role in reshaping our comprehension of diseases and target identification, approaches that blend AI with human expertise to identify and validate targets, and how it can elevate the field of chemical drug design and precision medicine. Additionally, we’ll explore how AI and machine learning initiatives measure up against the established and proven methods of drug discovery leading to successful market launches.

S2S - Science 2 Startup
2024-04-10
S2S is a forum for top scientists from around the world to present their ideas and interact with leading investors and executives in the Boston biotechnology hub.
Over 8 years, investigators from institutions including Brown, Carnegie Mellon, Columbia, Harvard, Johns Hopkins, MIT, Northwestern, NYU, Purdue, Scripps, UCLA, University of Iceland, University of Ottawa, University of Pennsylvania, University of Pittsburgh, Yale, and many more have presented their startup ideas at S2S and its precursor, the University Research and Entrepreneurship Symposium (URES).

AACR Annual Meeting
2024-04-05 - 2024-04-10
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

World Vaccine Conference
2024-04-02 - 2024-04-04
The Start-to-Finish of Vaccines
From research, immune profiling & clinical trials to manufacture and access.
Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

Gene Therapy for Rare Disorders Summit
2024-03-26 - 2024-03-29
This past year has seen more gene therapies approved by the FDA than the previous five years combined, and almost triple the number of clinical trials in gene therapy have been initiated in H1 of 2023 compared to the same time frame in the previous year.
To maximize the value of your late-stage gene therapy assets, the 7th Gene Therapy for Rare Disorders Summit is returning to tackle head-on the significant clinical, manufacturing, regulatory, and commercial challenges facing gene therapy programs today.
Bringing together key figures from industry, regulatory bodies, patient non-profits, payers, and key service providers, this is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic.
Join us to leverage essential insights from over 300 peers from leading biopharma companies with direct experience in driving gene therapies through the clinic and into the market. Keep your finger on the pulse, form connections with top decision-makers, and address your specific clinical, manufacturing, regulatory, and commercial bottlenecks to safeguard against costly delays and progress your gene therapies through the pipeline quickly and safely.
